Free Trial

NeuroBo Pharmaceuticals (NRBO) Insider Trading & Ownership

NeuroBo Pharmaceuticals logo
$2.67
+0.10 (+3.89%)
(As of 11/1/2024 ET)

NeuroBo Pharmaceuticals (NASDAQ:NRBO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.05%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7.96 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1,526.25
Get NRBO Insider Trade Alerts

Want to know when executives and insiders are buying or selling NeuroBo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NRBO Insider Buying and Selling by Quarter

NeuroBo Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2024St Co. Ltd Dong-AMajor ShareholderSell407$3.75$1,526.25  
6/23/2024St Co. Ltd Dong-AMajor ShareholderBuy2,544,530$3.13$7,964,378.90  
(Data available from 1/1/2013 forward)

NRBO Insider Trading Activity - Frequently Asked Questions

The list of insiders at NeuroBo Pharmaceuticals includes St Co. Ltd Dong-A. Learn more on insiders at NRBO.

1.05% of NeuroBo Pharmaceuticals stock is owned by insiders. Learn more on NRBO's insider holdings.

The following insider purchased NRBO shares in the last 24 months: St Co. Ltd Dong-A ($7,964,378.90).

Insiders have purchased a total of 2,544,530 NRBO shares in the last 24 months for a total of $7,964,378.90 bought.

The following insider sold NRBO shares in the last 24 months: St Co. Ltd Dong-A ($1,526.25).

Insiders have sold a total of 407 NeuroBo Pharmaceuticals shares in the last 24 months for a total of $1,526.25 sold.

NeuroBo Pharmaceuticals Key Executives

  • Mr. Hyung-Heon Kim (Age 49)
    CEO, President, Principal Executive & Director
    Compensation: $625.16k
  • Mr. Marshall H. Woodworth (Age 66)
    CFO, Principal Financial Officer & Principal Accounting Officer
    Compensation: $154.5k
  • Dr. Mi-Kyung Kim
    Chief Scientific Officer
  • Mr. Robert Homolka
    Senior Vice President of Clinical Operations


This page (NASDAQ:NRBO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners